Preclinical Development of AMX0114: An Antisense Oligonucleotide Inhibitor of Calpain-2
Time: 1:30 pm
day: Conference Day One
Details:
- Calpain-2 and axonal degeneration in neurodegenerative diseases
- In silico design and screening of novel ASOs to inhibit calpain-2
- Preclinical efficacy studies of AMX0114 in models of ALS
